These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3032215)

  • 21. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
    Takimoto T; Sato H; Ogura H
    Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z; Koprowski H; Andersson-Anvret M; Klein G
    J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recover of transforming Epstein-Barr virus (EBV) from Raji cells superinfected with NPC-KT EBV].
    Takimoto T; Iwawaki J; Ishikawa S; Tanaka S; Masuda K
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Nov; 90(11):1767-71. PubMed ID: 2833593
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene mapping of an Epstein-Barr virus isolate obtained from a nasopharyngeal carcinoma.
    Zhang HY; Dangel A; Takimoto T; Glaser R
    Intervirology; 1989; 30(1):52-60. PubMed ID: 2542179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of Epstein-Barr virus (EBV) infection in epithelial cells derived from the nasopharynx by cell fusion.
    Takimoto T; Morishita K; Furukawa M; Umeda R; Hatano M
    J Laryngol Otol; 1983 Aug; 97(8):719-26. PubMed ID: 6310010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunofluorescence and electron microscopic investigations of epithelial hybrid cells derived from nasopharyngeal carcinoma (NPC-KT).
    Takimoto T; Morishita K; Ishiguro H; Umeda R
    Auris Nasus Larynx; 1985; 12(1):37-45. PubMed ID: 2994615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predilection of a nasopharyngeal carcinoma-derived isolate of Epstein-Barr virus for infection of specific subsets of B lymphocytes.
    Tarr KL; Glaser R
    J Med Virol; 1989 Sep; 29(1):47-52. PubMed ID: 2555445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H
    J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of human interferon on cell proliferation and antigens induced by Epstein-Barr virus in epithelial hybrid cells derived from nasopharyngeal carcinoma.
    Takimoto T; Ishikawa S; Umeda R; Ogura H; Hatano M
    Otolaryngol Head Neck Surg; 1985 Aug; 93(4):500-4. PubMed ID: 2995902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein--Barr virus-induced cell fusion.
    Bayliss GJ; Wolf H
    Nature; 1980 Sep; 287(5778):164-5. PubMed ID: 6253791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
    Takimoto T; Ogura H; Sato H; Umeda R; Hatano M
    J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus-specific thymidine kinase.
    de Turenne-Tessier M; Ooka T; Calender A; de Thé G; Daillie J
    Int J Cancer; 1989 Jan; 43(1):45-8. PubMed ID: 2536007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus-epithelial cell interaction and its implication in the etiology of nasopharyngeal carcinoma.
    Lenoir G; de-The G
    IARC Sci Publ (1971); 1978; (20):377-84. PubMed ID: 215520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells.
    Busson P; Zhang Q; Guillon JM; Gregory CD; Young LS; Clausse B; Lipinski M; Rickinson AB; Tursz T
    Int J Cancer; 1992 Apr; 50(6):863-7. PubMed ID: 1372880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells.
    Sato H; Takimoto T; Tanaka S; Ogura H; Shiraishi K; Tanaka J
    J Virol; 1989 Aug; 63(8):3555-9. PubMed ID: 2545926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.